News

Catfish skin mucus yields promising antibacterial compound

Anne Frances Johnson
March 24, 2024

Scientists report they have extracted a compound with powerful antibacterial properties from the skin of farmed African catfish. Although additional testing is necessary to prove the compound is safe and effective for use as future antibiotic, the researchers say it could one day represent a potent new tool against antimicrobial-resistant bacteria such as extended-spectrum beta-lactamase (ESBL) producing E. coli.

Hedmon Okella is a postdoctoral researcher at the University of California, Davis, and led the project.

Scientists have extracted a compound with powerful antibacterial properties from the skin of farmed African catfish. The peptide could represent a potent new tool against antimicrobial-resistant infections, according to research presented at Discover BMB in San Antonio.
Scientists extracted a compound with powerful antibacterial properties from the skin of farmed African catfish. The peptide could be a potent new tool against antimicrobial-resistant infections, according to research presented at Discover BMB in San Antonio.

“The global public health threat due to antimicrobial resistance necessitates the search for safe and effective new antibacterial compounds,” Okella said. “In this case, fish-derived antimicrobial peptides present a promising source of potential leads.”

Okella will present the new research at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, which is being held March 23–26 in San Antonio.

For the study, the researchers extracted several peptides (short chains of amino acids) from African catfish skin mucus and used machine learning algorithms to screen them for potential antibacterial activity. They then chemically synthesized the most promising peptide, called NACAP-II, and tested its efficacy and safety on ESBL-E. coli and mammalian blood cells, respectively.

These tests showed that NACAP-II caused the bacteria to break open, or lyse, without appearing to harm the mammalian blood cells. “Preliminary findings indicate that this promising peptide candidate potentially disrupts the bacterial cell envelope to cause lysis at a very low concentration,” Okella said.

The place where the peptide was found — in the mucus on the skin of farmed African catfish — is not as unlikely as it may seem. As anyone who has tried to hold one can attest, fish are enveloped in a slippery layer of mucus. This mucus is known to protect the fish against infections by physically carrying germs off of the skin and by producing antimicrobial compounds such as the one Okella’s team isolated.

Many existing medicines are based on compounds that were first found in nature, and scientists speculate that marine and aquatic organisms represent a particularly rich — though largely untapped — source of bioactive compounds.

As a next step, the researchers plan to study the peptide’s effects in animal models and explore strategies to produce it inexpensively.

“We are currently utilizing chemical synthesis to upscale the production of this peptide that we believe will one day be of use as drug candidate in the battle against antimicrobial resistance,” Okella said.

Hedmon Okella will present this research from 4:30 to 6:30 p.m. CDT on Sunday, March 24, in the exhibit hall of the Henry B. González Convention Center (Poster Board No. 86) (abstract). 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anne Frances Johnson

Anne Frances Johnson is founder and lead science writer at Creative Science Writing based in Chapel Hill, North Carolina. 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.